Unoprostone
Clinical data | |
---|---|
Trade names | Rescula |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Pregnancy category |
|
Routes of administration | Topical (eye drops) |
ATC code | S01EE02 (WHO) |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Biological half-life | 14 min |
Excretion | Renal |
Identifiers | |
| |
CAS Number | 120373-36-6 120373-24-2 (isopropyl ester) |
PubChem (CID) | 5311236 |
DrugBank | DB06826 |
ChemSpider | 4470755 |
UNII | 6X4F561V3W |
KEGG | D08661 |
ChEMBL | CHEMBL1201407 |
ECHA InfoCard | 100.227.145 |
Chemical and physical data | |
Formula | C22H38O5 |
Molar mass | 382.534 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Unoprostone (INN) is a prostaglandin analogue. Its isopropyl ester, unoprostone isopropyl, was marketed under the trade name Rescula for the management of open-angle glaucoma and ocular hypertension, but is now discontinued in the US.[1]
References
This article is issued from Wikipedia - version of the 9/1/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.